Combining Mass Spectrometry with Genetic and Pharmacological Approaches to Discover and Validate LRRK2 Substrates (Joint with Max Planck, University College London and Harvard University)

Status	Finished
Effective start/end date	1/04/12 → 30/09/16

Project Details